Monday, October 15, 2018

Join me at CBI’s 14th Life Sciences Trade and Channel Strategies

CBI’s 14th Life Sciences Trade and Channel Strategies
December 11-12, 2018 | Philadelphia, PA
www.cbinet.com/trade

Are you ready for some channel strategy? Then join me at CBI’s 14th Life Sciences Trade and Channel Strategies Conference, being held this December in Philadelphia. CBI’s annual event has become our industry’s premier event focused on bio/pharma trade management.

I’ll kick things off with an interactive keynote address titled Drug Channels Update – Things to Watch in 2019. I'll highlight the key trends for the year ahead.

I'll also be moderating a panel with Wall Street experts. We'll delve further into industry trends and such other hot topics as stock market valuations, M&A, Amazon (of course), and more.

Drug Channels readers will save $300 off the standard rate
when you register with promo code HNB269 by October 26th.*

I hope you’ll join me in Philadelphia this December.

Regards,
Adam

A MESSAGE FROM CBI

Don’t miss the life science industry’s favorite event where the experts will share how to expand the playbook on product-specific network design, contracting and specialty distribution strategy.

Gain critical insights on industry trends, political impact, market dynamics and product-specific channel strategies. Key stakeholders come together to navigate the complex distribution and contracting landscape and discuss ways to optimize channel strategies in order to reach patients in need and provide the necessary services based on product type, site of care and reimbursement.

You can read all about it here.

The hottest topics addressed by the experts:
  • Drug Channels Update – Things to Watch in 2019
  • Adam J. Fein, Ph.D., CEO, Drug Channels Institute
  • Fragmentation and Customization Comes to Pharmaceutical Channels
  • William Roth, Founding Partner, Blue Fin Group
  • Market Economics and Emerging E-Commerce Players
  • Lance Wilkes, Senior Equity Analyst, Healthcare Services, Sanford C. Bernstein
  • Utilization Management and Copay Accumulator Impact
  • Jeff Henderson, Vice President, Head of Market Access and Government Affairs, US, Sobi, Inc.
  • Seamless Distribution Models for Orphan Therapies
  • Dave MacLeod, Senior Director, Patient Services and Channel Operations, Intercept Pharmaceuticals
  • Inaugural Specialty Pharmacy Working Group and Data Standard
  • John Klimek, R.Ph., Senior Vice President, Standards and Information Technology, NCPDP
  • Specialty Pharmacy and Distribution Trends Reshaping the Industry
  • Erika Chiles, Director, Pricing, Contracting and Trade, Neurocrine Biosciences, Inc.
  • Navigate the Biosimiliars Landscape for Market Access
  • Joseph P. Fur, Jr., Professor Emeritus of Economics, Widener University
PLUS! Customize your experience through a master class series:
  • Integrating Pharmacy and Medical Benefits for Better Health and Cost Reduction
  • Specialty Pharmacy Strategy Design for Biosimiliars and On-Market Brands
  • Navigate Limited and Closed Pharmacy Network Models
  • Accelerate Access through Patient Support Programs and Hub Services in an Increasingly Competitive Therapy Class
  • Advanced SP Contracting Course - Industry Best Practices During an Evolving and Consolidating Era
  • Managed Markets Compliance - Pharmaceutical Manufacturer Relationships with Specialty Pharmacies, Wholesalers, Distributors and GPOs
Visit www.cbinet.com/trade for further details and to register. Drug Channels readers will save $300 off the standard rate when they use code HNB269 and register prior to October 26th.*

See you there!

*Cannot be combined with other offers or used towards a current registration. Cannot be combined with special category rate or non-profit rates. Other restrictions may apply.


The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees.

No comments:

Post a Comment

Related Posts Plugin for WordPress, Blogger...